SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
基本信息
- 批准号:6328962
- 负责人:
- 金额:$ 18.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-16 至 2003-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Applicant's Abstract) The purpose of this proposed research
program is to develop new general methods for the construction of several
biologically active polypropionate natural products. The key step in the
syntheses of these compounds involves a concerted Lewis acid-promoted
rearrangement of an optically active epoxy alcohol to generate a
2-methyl-3-trialkylsilyloxyalkanal, namely an aldol product by a non-aldol
route. We have shown that all four possible enantiomers can be easily prepared
in high optical purity and good yields by this approach. We plan to extend this
research to prepare polypropionate chains with various absolute
stereochemistries. In particular, in order to illustrate the efficiency of this
process, we will finish the synthesis of two extremely strongly cytotoxic
agents, 13-deoxytedanolide 1 and tedanolide 2, and their close structural
analogues, by an application of this new approach to polypropionates.
13-Deoxytedanolide is extremely cytotoxic (IC50 94 pg/ml (P388)) and has high
antitumor activity (T/C 189 percent (P388) at 125 microg/kg) while tedanolide
is also extremely tumor inhibitory (ED50's 250 pg/ml (KB) and 16 pg/ml (PS))
and causes accumulation of cells in the S phase at very low concentrations (10
ng/ml). Thus they are very promising leads as new agents for cancer treatment.
The development of good general routes for their synthesis would not only
provide a potentially useful preparation of them (both were isolated from
marine sponges and are present in very small quantities) but also would allow
one to prepare several structural analogues unavailable from natural sources
which may show enhanced chemotherapeutic properties. We will also carry out
total syntheses of the important antibacterial agents, erythromycin A 3 and
oleandomycin 4. All of the advanced synthetic materials in the tedanolide
series will be tested for antitumor activity. In this way, we hope to figure
out just what parts of these complex molecules are required for the potent
activity and hopefully to prepare some simpler structures which still show
reasonable activity. Likewise the synthetic analogues of erythromycin and
oleandomycin will be tested for antibiotic activity. The successful
accomplishment of the research described in this proposal-namely, the
development of a really useful synthetic route to polypropionates and the
synthesis of the tedanolides, erythromycin A and oleandomycin and their
analogues-would be of great significance to medicinal chemistry. Because of the
medicinal importance of the targets, the efficiency of bond construction in the
syntheses, and the high intrinsic value of the new methods themselves, the
likelihood of an important contribution to health-related science is quite
high.
描述:(申请人摘要)本研究的目的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL E JUNG其他文献
MICHAEL E JUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL E JUNG', 18)}}的其他基金
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 18.6万 - 项目类别:
SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
- 批准号:
2010749 - 财政年份:1996
- 资助金额:
$ 18.6万 - 项目类别:
SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
- 批准号:
2608152 - 财政年份:1996
- 资助金额:
$ 18.6万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6592046 - 财政年份:1996
- 资助金额:
$ 18.6万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6624727 - 财政年份:1996
- 资助金额:
$ 18.6万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6475903 - 财政年份:1996
- 资助金额:
$ 18.6万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6778026 - 财政年份:1996
- 资助金额:
$ 18.6万 - 项目类别:
SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
- 批准号:
2837715 - 财政年份:1996
- 资助金额:
$ 18.6万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
2904802 - 财政年份:1996
- 资助金额:
$ 18.6万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 18.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 18.6万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 18.6万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 18.6万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 18.6万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 18.6万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 18.6万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 18.6万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 18.6万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 18.6万 - 项目类别:














{{item.name}}会员




